Fast Site Qualification for a Phase 2 Parkinson’s Disease Study

For a recent Phase 2 Parkinson’s disease study, the Rho team went above and beyond to qualify sites as quickly as possible. The first site qualification visit (SQV) was conducted in June, and 3 months later, our team had 50 sites identified and fully qualified. This success was due to excellent coordination and communication with the sites and working with experienced, knowledgeable CRAs.